New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer

Human Molecular Genetics

Volumn 17, Issue 12, 2008, Pages 1838-1844

  Guzman, Valeska B ^a   Yambartsev, Anatoly ^b   Goncalves Primo, Amador ^a   Silva, Ismael D C G ^a   Carvalho, Carmen R N ^a   Ribalta, Julisa C L ^a   Goulart, Luiz Ricardo ^c   Shulzhenko, Natalia ^a,d   Gerbase DeLima, Maria ^a   Morgun, Andrey ^a,d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; GAMMA INTERFERON; GENE PRODUCT; INDUCIBLE T CELL CO STIMULATOR; INTERLEUKIN 10; INTERLEUKIN 6; PROGRAMMED CELL DEATH RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RECOMBINATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

ANTIGENS, CD28; BRAZIL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON TYPE II; UTERINE CERVICAL NEOPLASMS;

EID: 44849097148     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddn077     Document Type: Article

References (57)

1. Schiffman, M., Hildesheim, A., Herrero, R. and Bratti, C. (2000) Human papillomavirus testing as a screening tool for cervical cancer. JAMA 283, 2525-2526.
2. Sarkar, A.K., Tortolero-Luna, G., Follen, M. and Sastry, K.J. (2005) Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study. Gynecol. Oncol., 99, S251-S261.
3. Apple, R.J., Erlich, H.A., Klitz, W., Manos, M.M., Becker, T.M. and Wheeler, C.M. (1994) HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat. Genet., 6, 157-162.
4. Gregoire, L., Lawrence, W.D., Kukuruga, D., Eisenbrey, A.B. and Lancaster, W.D. (1994) Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int. J. Cancer, 57 504-507.
5. Allen, M., Kalantari, M., Ylitalo, N., Pettersson, B., Hagmar, B., Scheibenpflug, L., Johansson, B., Petterson, U. and Glyllensten, U. (1996) HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens, 48, 32-37.
6. Sastre-Garau, X., Loste, M.N., Vincent-Salomon, A., Favre, M., Mouret, E., Rochefordiere, A., de la Durand, J.C., Tartour, F., Lepage, V. and Charron, D. 1996 Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-pisitive carcinoma of the cervix. Int. J. Cancer 69, 159-164.
7. Ferrera, A., Olivo, A., Alaez, C., Melchers, W.J. and Gorodezky, C. (1999) HLA DOA1 and DOB1 loci in Honduran women with cervical dysplasia and invasive cervical carcinoma and their relationship to human papillomavirus infection. Hum. Biol., 17, 367-379.
8. Maciag, P.C., Schlecht, N.F., Souza, P.S., Franco, E.L., Villa, L.L. and Petzl-Erler, M.L. (2000) Major histocompatiblity complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol. Biomarkers Prev., 9, 1183-1191.
9. Engelmark, M., Beskow, A., Magnusson, J., Erlich, H. and Gyllensten, U. (2004) Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer. Hum. Mol. Genet., 13, 1951-1958.
10. Zoodsma, M., Nolte, I.M., Schipper, M., Oosterom, E., van der Steege, G., de Vries, E.G., Te Meerman, G.J. and van der Zee, A.G. (2005) Analysis of the entire HLA region in susceptibility for cervical cancer: a comprehensive study. J. Med. Genet., 42, e49.
11. Carrington, M., Wang, S., Martin, M.P., Gao, X., Schiffman, M., Cheng, J., Herrero, R., Rodriguez, A.C., Kurman. R., Mortel. R. et al. (2005) Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J. Exp. Med., 201, 1069-1075.
12. Sharma, S., Sharma, A., Kumar, S., Sharma, S.K. and Ghosh, B. (2006) Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-alpha levels. Am. J. Respir. Cell Mol. Biol., 35, 488-495.
13. Ligers, A., Teleshova, N., Masterman, T., Huang, W.X. and Hillert, J. (2001) CTLA-4 gene expression is influenced by promoter and exon 1 Polymorphisms. Genes Immun., 2, 145-152.
14. Bergin, A.M., Balder, B., Kishore, S., Sward, K., Hahn-Zoric, M., Lowhagen, O., Hanson, L.A. and Padyukov, L. (2006) Common variations in the IL4R gene affect splicing and influence natural expression of the soluble isoform. Hum. Mutat., 27, 990-998.
15. Govan, V.A., Carrara, H.R., Sachs, J.A., Hoffman, M., Stanczuk, G.A. and Williamson, A.L. (2003) Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog., 2, 3.
16. Nogueira de Souza, N.C., Brenna, S.M., Campos, F., Syrjanen, K.J., Baracat, E.C. and Silva, I.D. (2006) Interleukin-6 polymorphisms and the risk of cervical cancer. Int. J. Gynecol. Cancer, 16, 1278-1282.
17. Stanczuk, G.A., Sibanda, E.N., Perrey, C., Chirara, M., Pravica, V., Hutchinson, I.V. and Tswana, S.A. (2001) Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding tor increased IL-10 production. Int. J. Cancer, 94, 792-794.
18. Stanczuk, G.A., Tswana, S.A., Bergstrom, S. and Sibanda, E.N. (2002) Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-beta1) gene in patients with invasive squamos cell carcinoma of the uterine cervix. Eur. J. Immunogenet., 29, 417-421.
19. Ghaderi, M., Nikitina, Z.L., Wallin, K., Wiklund, F., Hallmans, G., Lenner, P., Dillner, J. and Sanjeevi, C.B. (2001) Tumor necrosis factor A and MHC class I chain related gene A (MIC-A polymorphisms in Swedish patients with cervical cancer. Hum. Immunol., 62, 1153-1158.
20. Calhoun, E.S., McGovern, R.M., Janney, C.A., Cerhan, J.R., Iturria, S.J., Smith, D.I., Gostout, B.S. and Persing, D.H. (2002) Host genetic polymorphism analysis in cervical cancer. Clin. Chem., 48, 1218-1224.
21. Kirkpatrick, A., Bidwell, J., van den Brule, A.J., Meijer, C.J., Pawade, J. and Glew, S. (2004) TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol. Oncol., 92, 675-679.
22. Sun, T., Zhou, Y., Li, H., Han, X., Shi, Y., Wang, L., Miao, X., Tan, W., Zhao, D., Zhang, X. et al. (2005) FASL -844C polymorphisms is associated with increased activation-induced T cell death and risk of cervical cancer. J. Exp. Med., 202, 967-974.
23. Zoodsma, M., Nolte, I.M., Schipper, M., Oosterom, E., van der Steege, G., de Vries, E.G., Te Meerman, G.J. and van der Zee, A.G. (2005) Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int. J. Gynecol. Cancer, 15 (Suppl. 3), 282-290.
24. Nagel, R.L. (2005) Epistasis and the genetics of human diseases. C. R. Biol., 328, 606-615.
25. Moore, J.H. (2003) The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered., 56, 73-82.
26. Wang, S. and Zhao, H. (2003) Sample size needed to detect gene-gene interactions using association designs. Am. J. Epidemiol., 158 899-914.
27. Horng, J.T., Hu, K.C., Wu, L.C., Huang, H.D., Lin, F.M., Huang, S.L., Lai, H.C. and Chu, T.Y. (2004) Identifying the combination of genetic factors that determine susceptibility to cervical cancer. IEEE Trans. Inf. Technol. Biomed., 8, 59-66.
28. Cordell, H.J. (2002) Epistasis: What it means, what it doesn't mean, and statistical methods to detect it in humans. Hum. Mol. Genet., 11, 2463-2468.
29. Hoh, J. and Ott, J. (2003) Mathematical multi-locus approaches to localizing complex human trait genes. Nat. Rev. Genet., 4, 701-709.
30. Guzman, V.B., Morgun, A., Shulzhenko, N., Mine, K.L., Goncalves-Primo, A., Musatti, C.C. and Gerbase-Delima, M. (2005) Characterization of CD28, CTLA4, and ICOS polymorphisms in three Brazilian ethnic groups. Hum. Immunol., 66, 773-776.
31. Roh, J.W., Kim, M.H., Seo, S.S., Kim, S.H., Kim, J.W., Park, N.H., Song, Y.S., Park, S.Y., Kang, S.B. and Lee, H.P. (2002) Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett., 184, 57-63.
32. Dybikowska, A., Sliwinski, W., Emerich, J. and Podhajska, A.J. (2004) Evaluation of Fas gene promoter polymorphism in cervical cancer patients. Int. J. Mol. Med., 14, 475-478.
33. Govan, V.A., Constant, D., Hoffman, M. and Williamson, A.L. (2006) The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer, 6, 24.
34. Ritchie, M.D., Hahn, L.W., Roodi, N., Bailey, L.R., Dupont, W.D., Parl, F.F. and Moore, J.H. (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet., 69, 138-147.
35. Park, M.Y. and Hastie, T. (2008) Penalized logistic regression detecting gene interactions. Biostatistics., 9, 30-50.
36. Voigt, H., Schrama, D., Eggert, A.O., Vetter, C.S., Muller-Blech, K., Reichardt, H.M., Andersen, M.H., Becker, J.C. and Luhder, F. (2006) CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses. Clin. Exp. Immunol., 143 93-102.
37. Rudd, C.E. and Schneider, H. (2003) Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling. Nat. Rev. Immunol., 3, 544-556.
38. Wei, L., Sandbulte, M.R., Thomas, P.G., Webby, R.J., Homayouni, R. and Pfeffer, L.M. (2006) NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity. J. Biol. Chem., 281, 11678-11684.
39. Hajeer, A.H. and Hutchinson, I.V. (2001) TNF-alpha gene polymorphism: clinical and biological implications. Microsc. Res. Tech., 50 216-228.
40. Pravica, V., Perrey, C., Stevens, A., Lee, J.H. and Hutchinson, I.V. (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum. Immunol., 61, 863-866.
41. Mori, H., Hanabayashi, T., Yamada, Y. and Tamaya, T. (1990) Decrease in interferon-gamma production by peripheral blood mononuclear cells in patients with uterine cervical cancer. J. Clin. Immunol., 10 45-51.
42. Fernandes, A.P., Goncalves, M.A., Duarte, G., Cunha, F.Q., Simoes, R.T. and Donadi, E.A. (2005) HPV16, HPV18, and HIV infection may influence cervical cytokine intralesional levels. Virology, 334, 294-298.
43. Seresini, S., Origoni, M., Lillo, F., Caputo, L., Paganoni, A.M., Vantini, S., Longhi, R., Taccagni, G., Ferrari, A., Doglioni, C. et al. (2007) IFN-gamma produced by human papilloma virus-18 E6-specific CD4+ T cells predicts the clinical outcome after surgery in patients with high-grade cervical lesions. J. Immunol., 179, 7176-7183.
44. Bais, A.G., Beckmann, I., Lindemans, J., Ewing, P.C., Meijer, C.J., Snijders, P.J. and Helmerhorst, T.J. (2005) A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J. Clin. Pathol., 58, 1096-1100.
45. Sharma, A., Rajappa, M., Saxena, A. and Sharma, M. (2007) Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int. J. Gynecol. Cancer, 17, 879-885.
46. El-Sherif, A.M., Seth, R., Tighe, P.J. and Jenkins, D. (2001) Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J. Pathol., 195, 179-185.
47. Spilianakis, C.G., Lalioti, M.D., Town, T., Lee, G.R. and Flavell, R.A. (2005) Interchromosomal associations between alternatively expressed loci. Nature, 435, 637-645.
48. Lomvardas, S., Barnea, G., Pisapia, D.J., Mendelsohn, M., Kirkland, J. and Axel, R. (2006) Interchromosomal interactions and olfactory receptor choice. Cell, 126, 403-413.
49. Koch, O., Rockett, K., Jallow, M., Pinder, M., Sisay-Joof, F. and Kwiatkowski, D. (2005) Investigation of malaria susceptibility determinants in the IFNG/IL26/IL22 genomic region. Genes Immun., 6, 312-318.
50. Schlecht, N.F., Kulaga, S., Robitaille, J., Ferreira, S., Santos, M., Miyamura, R.A., Duarte-Franco, E., Rohan, T.E., Ferenczy, A., Villa, L.L. and Franco, E.L. (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA, 286 3106-3114.
51. Cuschieri, K.S., Cubie, H.A., Whitley, M.W., Gilkison, G., Arends, M.J., Graham, C. and McGoogan, E. (2005) Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J. Clin. Pathol., 58, 946-950.
52. Gustincich, S., Manfioletti, G., Del, S.G., Schneider, C. and Carninci, P. (1991) A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques, 11, 298-300, 302.
53. Benjamini, Y. and Hochberg, Y. (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Statist. Soc. B, 57, 298-300.
54. Excoffier, L., Laval, G. and Schneider, S. (2005) Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evolutionary Bioinformatics Online, 1, 47-50.
55. Shao, J. (1995) The Jackknife and Bootstrap, Springer.
56. Fishman, G.S. (1995) Monte Carlo: Concepts, Algorithms, and Applications, Springer Verlag.
57. Cochran, W.G. (1954) The Combination of Estimates from Different Experiments. Biometrics, 10, 101-129.